???pagination.result.count???
???pagination.result.page???
1
Tight Chk1 Levels Control Replication Cluster Activation in Xenopus. , Platel M., PLoS One. June 5, 2015; 10 (6): e0129090.
Cell cycle-regulated multi-site phosphorylation of Neurogenin 2 coordinates cell cycling with differentiation during neurogenesis. , Ali F., Development. October 1, 2011; 138 (19): 4267-77.
WNK2 kinase is a novel regulator of essential neuronal cation-chloride cotransporters. , Rinehart J., J Biol Chem. August 26, 2011; 286 (34): 30171-80.
Developmental downregulation of Xenopus cyclin E is phosphorylation and nuclear import dependent and is mediated by ubiquitination. , Brandt Y., Dev Biol. July 1, 2011; 355 (1): 65-76.
Identification of Xenopus cyclin-dependent kinase inhibitors, p16Xic2 and p17Xic3. , Daniels M., Gene. November 10, 2004; 342 (1): 41-7.
G1/S phase cyclin-dependent kinase overexpression perturbs early development and delays tissue-specific differentiation in Xenopus. , Richard-Parpaillon L ., Development. June 1, 2004; 131 (11): 2577-86.
Inhibition of the cell cycle is required for convergent extension of the paraxial mesoderm during Xenopus neurulation. , Leise WF., Development. April 1, 2004; 131 (8): 1703-15.
The developmental expression of cell cycle regulators in Xenopus laevis. , Vernon AE., Gene Expr Patterns. May 1, 2003; 3 (2): 179-92.
Co-ordinating retinal histogenesis: early cell cycle exit enhances early cell fate determination in the Xenopus retina. , Ohnuma S ., Development. May 1, 2002; 129 (10): 2435-46.
Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2. , Porter LA., J Cell Biol. April 29, 2002; 157 (3): 357-66.
Cyclin E morpholino delays embryogenesis in Xenopus. , Audic Y ., Genesis. July 1, 2001; 30 (3): 107-9.
Giant eyes in Xenopus laevis by overexpression of XOptx2. , Zuber ME ., Cell. August 6, 1999; 98 (3): 341-52.
Nuclear proteins of quiescent Xenopus laevis cells inhibit DNA replication in intact and permeabilized nuclei. , Fang J., J Cell Biol. June 1, 1996; 133 (5): 955-69.
Cellular effects of olomoucine, an inhibitor of cyclin-dependent kinases. , Abraham RT., Biol Cell. January 1, 1995; 83 (2-3): 105-20.